- 03-09-12 | Antiangiogenic Activity of Aganirsen in Nonhuman Primate and Rodent Models of Retinal
Neovascular Disease after Topical Administration01-11-12 | The Use of the African Green Monkey as a Preclinical Model for Ocular Pharmacokinetic Studies03-21-11 | Optimization of laser-induced choroidal neovascularization (CNV) in African green monkeys02-22-10 | Establishing a model spinal cord injury in the African green monkey for the preclinical
evaluation of biodegradable polymer scaffolds seeded with human neural stem cells01-01-09 | Exploration of the African green monkey as a preclinical pharmacokinetic model:
oral pharmacokinetic parameters and drug–drug interactions04-17-08 | LNA-mediated microRNA silencing in non-human primates01-23-08 | Exploration of the African Green Monkey as a Preclinical Pharmacokinetic Model:
Intravenous Pharmacokinetic Parameters08-18-99 | Striatal Dopaminergic Correlates of Stable Parkinsonism and Degree of Recovery in
Old-World Primates One Year After MPTP Treatment01-10-99 | Inflammatory responses and their impact on b-galactosidase transgene expression
following adenovirus vector delivery to the primate caudate nucleus08-15-97 | Enduring Cognitive Deficits and Cortical Dopamine Dysfunction in Monkeys After
Long-Term Administration of Phencyclidine
